METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE 20 mg/1
methylphenidate hydrochloride extended release · TABLET · KVK-Tech, Inc.
Methylphenidate Hydrochloride Extended Release is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. This 20 mg tablet is taken by mouth and releases the medication gradually throughout the day to help improve focus and reduce impulsive behavior.
Key Facts
- Brand Name
- METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE
- Generic Name
- methylphenidate hydrochloride extended release
- NDC Code (Product)
10702-076- Manufacturer
- KVK-Tech, Inc.
- Strength
- 20 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule II (Controlled)
- Application #
- ANDA207488
- Marketing Start
- 06/09/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE used for?
Methylphenidate Hydrochloride Extended Release is a prescription stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. This 20 mg tablet is taken by mouth and releases the medication gradually throughout the day to help improve focus and reduce impulsive behavior.
Is METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE a controlled substance?
Yes, METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE is classified as CII under the DEA Controlled Substances Act.
What is the generic name for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE?
The generic name for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE is methylphenidate hydrochloride extended release. There are no other listed brand versions of methylphenidate hydrochloride extended release.
What is the NDC code for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE 20 mg/1?
The NDC (National Drug Code) for METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE 20 mg/1 is 10702-076, listed by KVK-Tech, Inc..
Other METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)